CONNECT WITH US
Funding Tracker

Funding Tracker

NuSynth raises Rs 36.5 Cr in seed round led by Avaana Capital, Shastra VC

Entrackr logo

Published on

Add as a preferred source on Google
NuSynth raises Rs 36.5 Cr in seed round led by Avaana Capital, Shastra VC

NuSynth Technologies, a Bengaluru based chemical process innovation startup, has raised Rs 36.5 crore (around $4 million) in a seed funding round co-led by Avaana Capital and Shastra VC.

The startup is developing a platform to redesign chemical synthesis processes by evaluating raw materials, reaction pathways and process economics.

NuSynth uses predictive synthesis models and an AI engine that processes experimental data to inform future research cycles. Its platform focuses on developing alternative synthesis routes with changes to cost, yield, safety, sustainability and scalability.

The startup is initially focusing on pharmaceuticals and electronics chemicals. It plans to develop proprietary chemical processes for commercial applications across multiple chemistry-led sectors.

The fresh capital will be used to develop its R&D and technology capabilities, build an initial portfolio of proprietary processes, strengthen scale-up capabilities and expand the team.

NuSynth was founded by Poorvank Purohit, former MD and CEO of Solara Active Pharma Sciences, and Dr Ramesha A R, a postdoctoral researcher at the National Institutes of Health (NIH), Washington. The founding team also includes Abhishek Deo and Dipak Bajaj, who have worked with companies such as Zetwerk, Mstack, Ola, JPMorgan, BlackBuck and SUN Mobility.

According to the company, its platform is designed to reduce the time required for chemical R&D by using data from previous experiments to guide subsequent research.



Source link
Related Topics:Funding Tracker

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.